Clinical trial

NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study

NCT01394978

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-06-01

PhaseNA

Study timeline

Study start (unknown)2011-06-01Date precision: month

Registry last updated2021-07-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Lung Tumorunresolved

Interventions

ControlOTHER

ProGEL Pleural Air Leak Sealant with standard surgical closureDEVICE

ProGEL Pleural Air Leak Sealant without standard surgical closureDEVICE

Sponsors & collaborators

C. R. Bardlead sponsor

Mapped research locations

BostonMassachusetts, United States3 AtlantaGeorgia, United States2 BirminghamAlabama, United States2 IndianapolisIndiana, United States2 BaltimoreMaryland, United States1 SeattleWashington, United States1 TampaFlorida, United States1 JacksonvilleFlorida, United States1 RochesterMinnesota, United States1 RichmondVirginia, United States1 MadisonWisconsin, United States1 WorcesterMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01394978 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.